Therapeutic agent for rheumatic disease

Details Therapeutic agent for rheumatic disease Therapeutic agent for rheumatic disease

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/407 (2006.01) A61K 31/4412 (2006.01) A61K 31/538 (2006.01) A61K 38/21 (2006.01) A61P 19/02 (2006.01) C07K 16/28 (2006.01) C12P 21/08 (2006.01)

Patent

CA 2158822

The present invention relates to a therapeutic agent for rheumatic disease comprising an anti-Fas monoclonal antibody, or the combination of an anti-Fas monoclonal antibody and a medical substance having an inhibitory effect of cell proliferation as an active ingredient. The anti-Fas monoclonal antibody of this invention reacts with the Fas antigen in synovial cells of patients with rheumatoid arthritis, especially the human Fas antigen specifically and expresses apoptosis on synovial cells.

Affiliated with

Also associated with

Rating

Therapeutic agent for rheumatic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic agent for rheumatic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic agent for rheumatic disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1358943